10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,338,877 | -46.5% | 34,767 | -21.1% | 0.00% | 0.0% |
| Q2 2023 | $2,501,611 | -32.5% | 44,089 | -39.0% | 0.00% | -50.0% |
| Q1 2023 | $3,708,743 | +118.0% | 72,267 | +78.2% | 0.00% | +100.0% |
| Q4 2022 | $1,701,045 | +46.4% | 40,559 | +51.1% | 0.00% | 0.0% |
| Q2 2022 | $1,162,000 | -89.6% | 26,840 | -82.4% | 0.00% | -87.5% |
| Q1 2022 | $11,180,000 | -42.5% | 152,534 | -17.7% | 0.01% | -33.3% |
| Q4 2021 | $19,429,000 | -30.9% | 185,373 | -4.0% | 0.01% | -40.0% |
| Q3 2021 | $28,108,000 | -25.2% | 193,079 | +0.6% | 0.02% | -23.1% |
| Q2 2021 | $37,592,000 | – | 191,969 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |